We recently published a list of 15 Best Bank Stocks to Buy According to Billionaires. In this article, we are going to take a ...

Synchrony Financial SYF shares have declined 16.1% in the past month due to continued investor concerns about its credit ...

CareCredit is different than your average ... Over the years, it's evolved into a more robust financing option issued by Synchrony Bank that covers a plethora of health and wellness services.

Synchrony Bank has financing for healthcare procedures and purchases available through its CareCredit product. It does not offer checking accounts, mortgages, investments, or other products that ...

Given the lack of competitive advantage, Synchrony’s retail card’s return on equity is likely to trend lower. Unlike the retail card segment, payment solutions and CareCredit are heavily ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $74.89, a high estimate of $85.00, and a low estimate of $66.00. This current average has increased by 5.79 ...

The company’s CareCredit platform continues to show strong growth, particularly in the healthcare sector, where Synchrony is expanding its network reach. Despite divesting Pets Best, Synchrony ...

Synchrony Financial ... cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures). Key Indicators: Synchrony ...

However, we believe the dip offers a massive buying opportunity, given SYF’s improving digital capabilitiesand expanding CareCredit platformand financial service offerings. Let’s delve deeper.